Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Damås JK, Kleveland O(2024) Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI Int J Cardiol, 132613(in press) DOI 10.1016/j.ijcard.2024.132613, PubMed 39374793
Svenningsen A, Söderström S, Bucher Sandbakk S, Gullestad L, Bønaa KH, Wisløff U, Hollekim-Strand SM(2024) Mind the intention-behavior gap: a qualitative study of post-myocardial infarction patients' beliefs and experiences with long-term supervised and self-monitored physical exercise BMC Sports Sci Med Rehabil, 16(1), 204 DOI 10.1186/s13102-024-00987-2, PubMed 39334432
Kindberg KM, Broch K, Andersen GØ, Anstensrud AK, Åkra S, Woxholt S, Tøllefsen IM, Ueland T, Amundsen BH, Kløw NE, Halvorsen B, Dahl TB, Huse C, Murphy SL, Damås JK, Opdahl A, Wiseth R, Gullestad L, Aukrust P, Santos-Gallego C, Seljeflot I, Stokke MK, Helseth R(2024) Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size JACC Adv, 3(9), 101193 DOI 10.1016/j.jacadv.2024.101193, PubMed 39247678